首页> 美国卫生研究院文献>Reproductive Medicine and Biology >Is human chorionic gonadotropin supplementation beneficial for frozen and thawed embryo transfer in estrogen/progesterone replacement cycles?: A randomized clinical trial
【2h】

Is human chorionic gonadotropin supplementation beneficial for frozen and thawed embryo transfer in estrogen/progesterone replacement cycles?: A randomized clinical trial

机译:人绒毛膜促性腺激素补充剂在雌激素/孕激素替代周期中是否有利于冷冻和解冻的胚胎移植?:一项随机临床试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AimHuman chorionic gonadotropin (hCG) is used frequently for luteal support in fresh in vitro fertilization cycles as it induces progesterone secretion from the ovaries after oocyte retrieval and modulates the endometrium for implantation in fresh cycles. In contrast, hCG is not usually used for the transfer of cryopreserved‐thawed embryos in estrogen/progesterone replacement cycles because ovulation is suppressed. However, several studies have shown that luteinizing hormone and hCG receptors are present in the human endometrium and that hCG can directly induce the decidualization of endometrial stromal cells in vitro. Thus, this study evaluated whether hCG supplementation can be beneficial for cryopreserved‐thawed embryo transfer in estrogen/progesterone replacement cycles.
机译:AimHuman绒毛膜促性腺激素(hCG)在新鲜的体外受精周期中经常用于黄体支持,因为它诱导卵母细胞取回后卵巢中的孕酮分泌,并调节子宫内膜以在新鲜周期中植入。相反,由于排卵受到抑制,hCG通常不用于雌激素/孕酮置换周期中冷冻保存的解冻胚胎的转移。然而,一些研究表明,人子宫内膜中存在促黄体生成激素和hCG受体,hCG可以在体外直接诱导子宫内膜基质细胞的蜕膜化。因此,本研究评估了补充hCG是否对雌激素/孕激素替代周期中冻融融化的胚胎移植有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号